Address
1400 16th Street
San Francisco, CA 94103
United States of America (the)
Phone
415 374 7782
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
1700
First IPO Date
February 12, 2015
| Name | Title | Pay | Year Born |
| Kenneth D. Knight | President, Chief Executive Officer & Director | 1.4M | 1961 |
| Randal W. Scott | Co-Founder & Chairman of the Board | 50,000 | 1958 |
| Shelly D. Guyer | Chief Sustainability Officer | 430,444 | 1960 |
| W. Michael Korn | Chief Medical Officer | 751,951 | N/A |
| Thomas R. Brida | General Counsel, Chief Compliance Officer & Secretary | 776,722 | 1971 |
| David Sholehvar | Chief Operating Officer | 0 | 1968 |
| Robert Guigley | Chief Commercial Officer | 0 | N/A |
| Hoki Luk | Head of Investor Relations and Capital Markets | 0 | 1976 |
| Ana J. Schrank | Chief Accounting Officer & Chief Financial Officer | 0 | 1966 |
| Desarie French | Chief Talent Officer | 0 | N/A |
Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.